First Time Loading...

Provention Bio Inc
NASDAQ:PRVB

Watchlist Manager
Provention Bio Inc Logo
Provention Bio Inc
NASDAQ:PRVB
Watchlist
Price: 24.98 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

PRVB Price Targets Summary
Provention Bio Inc

There are no price targets for PRVB.
PRVB Lowest Forecast
Wall Street Target
Not Available
PRVB Average Forecast
Wall Street Target
Not Available
PRVB Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Provention Bio Inc Competitors:
Price Targets
G
GHRS
GH Research PLC
177% Upside
R
RHONEMA
Rhone Ma Holdings Bhd
14% Upside
O
ORNBV
Orion Oyj
10% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
30% Upside
G
GHRS
GH Research PLC
177% Upside
R
RHONEMA
Rhone Ma Holdings Bhd
14% Upside
O
ORNBV
Orion Oyj
10% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
30% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
18% Upside
AUROPHARMA
Aurobindo Pharma Ltd
2% Upside
ZYDUSLIFE
Zydus Lifesciences Ltd
19% Downside
CIPLA
Cipla Ltd
1% Upside

Revenue
Forecast

Revenue Estimate
Provention Bio Inc

The compound annual growth rate of Provention Bio Inc's revenue for the next 3 years is 219%.

N/A
Past Growth
219%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Provention Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Provention Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
What are analyst estimates?

See Also

Summary
PRVB intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRVB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRVB stock valuation using valuation multiples.
Wall Street Estimates
PRVB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRVB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRVB's stock price target?
Not Available

PRVB doesn't have any price targets made by Wall Street professionals.

What is Provention Bio Inc's Revenue forecast?
Projected CAGR
219%

The compound annual growth rate of Provention Bio Inc's revenue for the next 3 years is 219%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.